CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Origin Life Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Origin Life Sciences Inc
2 RESEARCH WAY, THIRD FLOOR
Phone: (609) 250-6000p:609 250-6000 PRINCETON, NJ  08540  United States Fax: (302) 655-5049f:302 655-5049
Business Summary
Origin Life Sciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of proprietary patented high-energy plasma device that generates nitric oxide (NO) in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream can be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and skin and soft tissue infections (SSTIs). The cornerstone of the plasma/NO therapy is the Company's patented delivery platform, Ionojet, which allows it to turn atmospheric air into a plasma/NO stream that has been shown in investigations: to be non-toxic, to generate NO activity up to three centimeters below the skin, and to stimulate sustained biological activity in tissue for up to an hour after delivery of the therapy.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer MichaelPreston 78 1/1/2015 1/1/2010
Deputy Chairman and Chief Medical Officer DavidDantzker 80 1/1/2012
Chief Financial Officer, Treasurer, Secretary JohnnyFernandes 67 1/1/2018 11/1/2014
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Advanced Plasma Therapies, Inc.
Advanced Plasma Therapies, Inc.
OLSI
Origin Agribusiness Limited
Origin Life Sciences Limited
Origin, Inc

General Information
Outstanding Shares: 19,743,287 (As of 9/30/2023)
Stock Exchange: ASE
Federal Tax Id: 273705184
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024